Responses

Download PDFPDF

Extended report
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Preemptive Treatment of Hepatitis B in Patients of Rheumatoid Arthritis and Spondyloarthritis Using Tumor Necrosis Factor-alpha Antagonist: an Individualised Management.
    • James CC Wei, Chief
    • Other Contributors:
      • Pui Ying Leong, Cheng-Han Wu, Chia-Yin Chen, Chun-Huang Huang, Min-Ling Tsai, Yi-Ling Chen, Kai-Jieh Yeo, Jaw-Ming Cherng, Soo-Ray Wang, Gregory J Tsay and Pei-Jer Chen

    Dear editor,

    We are writing in response to 'Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumor necrosis factor alpha therapy' by Lan, et al[1]. We performed a similar retrospective study in the rheumatoid arthritis and the spondyloarthritis patients comorbid with chronic hepatitis B treated by anti-tumor ne...

    Show More
    Conflict of Interest:
    None declared.